Acambis chronicles

Acambis chronicles

From its five-year high of 393p on Sept. 15, 2003, through July 25 of this year, Acambis (LSE:ACM) has lost 70% of its value. The stock jumped 60% to 185.5p on July 28 after sanofi-aventis (Euronext:SAN; NYSE:SNY) announced after the markets closed on Friday, July 25, that it would

Read the full 508 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE